Cryoport Inc (CYRX) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Cryoport Inc $17.98, price $17.49, upside +2.8%, quality 50 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Cryoport Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range $4.70 – $83.29 · fair‑value band $13.48 – $22.47 · the $17.49 price screens below the $17.98 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Cryoport in your weekly email
Every Wednesday you see whether Cryoport is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry.
Show more
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Stock analysis
Cryoport Inc (CYRX) currently trades at $17.49, while our model-based Fair Value estimate is $17.98, implying the stock looks roughly 2.7% fairly valued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $72.18 per share, and 7 of the 12 models we run sit above the $17.49 price.
Bear case: the Dividend Discount group reads lowest at $2.03, and 5 of the 12 models stay below the price. Evidence for this calculation is medium.
Scenario range: $13.48 (bear) to $22.47 (bull), the price of $17.49 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Industrials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Cryoport Inc reported revenue of $176M in FY2025 versus $223M in FY2021, a compound −5.7%/yr. Reported net income was $78.3M in FY2025.
Key figures
Market cap $876M · P/S ratio 4.14 · EPS (TTM) $−0.9000 · Dividend yield 1.1% · Net margin 44.4% · Return on equity −8.2% · Return on assets (EBIT) −5.6% · Operating margin −20.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (medium confidence).
What moves the price
The share trades about 1% below its 52-week high and 127% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −28% fair-value upside, at 3%, CYRX screens cheaper than that median.
Fair Value models
Bear $13.48Fair Value $17.98Bull $22.47
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−24.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.5%
Start year 2020 (pandemic). Over 10 years: +40.5% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+41.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−38.1% (2020) → −20.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
News mood ⓘNews mood, the average tone of recent news (95 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Integrated Freight & Logistics · 208 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Cryoport Inc Fair Value". https://www.fairvalue-calculator.com/stock/CYRX
Frequently asked questions
Is Cryoport Inc (CYRX) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $17.98 versus a price of $17.49, about +3% upside (fairly valued).
What is the fair value of CYRX?
Our model-based fair value for Cryoport Inc is $17.98 (as of Sep 23, 2026), built from audited fundamentals. The current price: $17.49.
What is the quality score of CYRX?
Cryoport Inc has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cryoport Inc (CYRX)?
Our model-based price target is the fair value of $17.98 (as of Sep 23, 2026) from 12 valuation models. Cautious scenario $13.48, optimistic scenario $22.47. It is a calculation from audited fundamentals, not an analyst target.
What is the Cryoport Inc stock forecast for 2026?
Our models put fair value at $17.98, about +3% upside versus a price of $17.49 (fairly valued). Cautious scenario $13.48, optimistic scenario $22.47. The calculation is refreshed regularly with new filings.
What is the revenue of Cryoport Inc (CYRX)?
Cryoport Inc reported trailing-twelve-month revenue of about $183M (latest available figure, as of Sep 23, 2026).
Does Cryoport Inc pay a dividend?
Cryoport Inc currently shows a dividend yield of about 1.06% relative to its recent price (as of Sep 23, 2026).
What is the intrinsic value of Cryoport Inc (CYRX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cryoport Inc it is $17.98 per share (as of Sep 23, 2026), against a price of $17.49. It is the blended result of 12 valuation models (cash flow, earnings, asset, dividend).
Is Cryoport Inc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, CYRX trades below its calculated fair value: price $17.49, fair value $17.98, a gap of about +3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CYRX?
No. The price is what the market pays today ($17.49); the fair value is what the company's own numbers justify ($17.98). For Cryoport Inc the two are $0.4900 per share apart. That gap is exactly why we show both numbers side by side.
How much is Cryoport Inc worth?
The market values Cryoport Inc at about $876M (market capitalisation, as of Sep 23, 2026). Per share that is $17.49; our models calculate a fair value of $17.98 per share.
What do the bullish and bearish scenarios say about CYRX?
Our models span a range for Cryoport Inc: cautious scenario $13.48, base $17.98, optimistic $22.47 per share (as of Sep 23, 2026, price $17.49). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of CYRX?
The PEG ratio of Cryoport Inc is 62.13 (P/E divided by earnings growth, as of Sep 23, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Cryoport Inc (CYRX)?
Balance-sheet figures for Cryoport Inc (as of Sep 23, 2026): return on equity −8.2%, debt of 0.00 per unit of equity. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is CYRX from its 52-week high?
Cryoport Inc trades at $17.49, about 1% below its 52-week high of $17.62 and 127% above the low of $7.72 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $17.98 is for.
Which stocks are comparable to Cryoport Inc?
From the same area (Industrials) we also value United Parcel Service, Inc, FedEx Corporation, Deutsche Post AG, DSV A/S, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cryoport Inc stock attractive at the current price?
The data as of Sep 23, 2026: price $17.49, calculated fair value $17.98 (+3%), Quality Score 50/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CYRX calculated?
We run Cryoport Inc through 12 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $17.98, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Cryoport Inc currently trades 3 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cryoport Inc (CYRX)?
The closing price on Sep 23, 2026 was $17.49. Our model-based fair value is $17.98, about +3% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cryoport Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Key figures of Cryoport Inc
How large is the market capitalisation of Cryoport Inc (CYRX)?
The market capitalisation of Cryoport Inc is $876M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cryoport Inc (CYRX)?
The price-to-sales ratio of Cryoport Inc is 4.14 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cryoport Inc (CYRX)?
Earnings per share at Cryoport Inc are $−0.9000. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Cryoport Inc (CYRX)?
The dividend yield of Cryoport Inc is 1.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Cryoport Inc (CYRX)?
The net margin of Cryoport Inc is 44.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cryoport Inc (CYRX)?
The return on equity (ROE) of Cryoport Inc is −8.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cryoport Inc (CYRX)?
On an EBIT basis the return on assets of Cryoport Inc is −5.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cryoport Inc (CYRX)?
The operating margin of Cryoport Inc is −20.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cryoport Inc (CYRX)?
Revenue at Cryoport Inc is growing +16.5% versus a year earlier (3y avg −7.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Cryoport Inc (CYRX) generate?
The free cash flow of Cryoport Inc is −$28.1M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Cryoport Inc (CYRX) hold?
Cryoport Inc holds more cash than debt, $19.8M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Cryoport Inc in the live analysis
One click puts Cryoport Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Some data
Sep 23, 2026